Yohei Misumi

2.7k total citations
109 papers, 1.5k citations indexed

About

Yohei Misumi is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Yohei Misumi has authored 109 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 34 papers in Physiology and 22 papers in Nephrology. Recurrent topics in Yohei Misumi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (82 papers), Alzheimer's disease research and treatments (31 papers) and Parathyroid Disorders and Treatments (21 papers). Yohei Misumi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (82 papers), Alzheimer's disease research and treatments (31 papers) and Parathyroid Disorders and Treatments (21 papers). Yohei Misumi collaborates with scholars based in Japan, United States and Sweden. Yohei Misumi's co-authors include Yukio Ando, Mitsuharu Ueda, Konen Obayashi, Taro Yamashita, Hirofumi Jono, Masayoshi Tasaki, Teruaki Masuda, Satoru Shinriki, Toshinori Oshima and Yasuteru Inoue and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yohei Misumi

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohei Misumi Japan 23 1.3k 388 295 255 232 109 1.5k
Masayoshi Tasaki Japan 23 1.2k 0.9× 336 0.9× 236 0.8× 174 0.7× 242 1.0× 80 1.4k
Taro Yamashita Japan 28 2.0k 1.5× 597 1.5× 449 1.5× 390 1.5× 341 1.5× 130 2.4k
Jeff Packman United States 8 1.2k 0.9× 252 0.6× 172 0.6× 257 1.0× 344 1.5× 12 1.3k
Jian Guan China 15 837 0.7× 150 0.4× 162 0.5× 107 0.4× 233 1.0× 25 1.0k
Mohga El‐Abbadi United States 14 439 0.3× 342 0.9× 367 1.2× 55 0.2× 69 0.3× 15 1.1k
Minjing Zou Saudi Arabia 30 1.1k 0.8× 54 0.1× 126 0.4× 76 0.3× 638 2.8× 71 2.1k
Chunping Yu China 21 1.1k 0.9× 94 0.2× 120 0.4× 134 0.5× 322 1.4× 50 1.8k
Shujun Lin China 16 822 0.6× 55 0.1× 65 0.2× 86 0.3× 354 1.5× 49 1.4k
Shiying Cui Canada 17 1.2k 0.9× 88 0.2× 436 1.5× 104 0.4× 113 0.5× 24 1.8k
Sharmistha Chakraborty United States 23 891 0.7× 70 0.2× 34 0.1× 112 0.4× 303 1.3× 41 1.4k

Countries citing papers authored by Yohei Misumi

Since Specialization
Citations

This map shows the geographic impact of Yohei Misumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Misumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Misumi more than expected).

Fields of papers citing papers by Yohei Misumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Misumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Misumi. The network helps show where Yohei Misumi may publish in the future.

Co-authorship network of co-authors of Yohei Misumi

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Misumi. A scholar is included among the top collaborators of Yohei Misumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Misumi. Yohei Misumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muchtar, Eli, Fabian aus dem Siepen, Márcia Waddington‐Cruz, et al.. (2025). Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines. Amyloid. 32(2). 93–116. 1 indexed citations
2.
Luigetti, Marco, Dianna Quan, John L. Berk, et al.. (2024). Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study. Neurology and Therapy. 13(3). 625–639. 2 indexed citations
3.
Kido, Jun, Kimiyasu Egami, Yohei Misumi, et al.. (2023). X-linked intellectual disability related to a novel variant of KLHL15. Human Genome Variation. 10(1). 21–21.
4.
5.
Misumi, Yohei, et al.. (2022). Effects of Intensive Exercise on Cognitive Dysfunction in Patients With Pure Cerebellar Degeneration: A Single-Arm Pilot Study. Annals of Rehabilitation Medicine. 46(5). 263–273. 1 indexed citations
6.
Inoue, Yasuteru, Masayoshi Tasaki, Teruaki Masuda, et al.. (2022). α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation. Cellular and Molecular Life Sciences. 79(8). 462–462. 2 indexed citations
7.
Ando, Yukio, Taro Yamashita, Yohei Misumi, et al.. (2020). Clinical, pathological, and proteomic characteristics of newly diagnosed amyloidosis patients: Experience from a single referral center in Japan. Neurology and Clinical Neuroscience. 9(1). 37–44. 2 indexed citations
8.
Misumi, Yohei, Teruaki Masuda, Masayoshi Tasaki, et al.. (2020). Plasma Growth Differentiation Factor 15: A Novel Tool to Detect Early Changes of Hereditary Transthyretin Amyloidosis. ESC Heart Failure. 8(2). 1178–1185. 6 indexed citations
9.
Ueda, Mitsuharu, Mineyuki Mizuguchi, Barbara Kluve‐Beckerman, et al.. (2019). A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. Journal of Biological Chemistry. 294(29). 11259–11275. 16 indexed citations
10.
Ikeda, Tokunori, Teruaki Masuda, Taro Yamashita, et al.. (2017). Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin. Scientific Reports. 7(1). 1579–1579. 13 indexed citations
11.
12.
Yamashita, Satoshi, Yohei Misumi, Shoji Honda, et al.. (2014). Gait Disturbance due to Foot Drop Is Refractory to Treatment in Nonsystemic Vasculitic Neuropathy. European Neurology. 71(3-4). 180–186. 8 indexed citations
13.
Obayashi, Konen, Masayoshi Tasaki, Hirofumi Jono, et al.. (2013). Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine. Clinica Chimica Acta. 419. 127–131. 6 indexed citations
14.
Misumi, Yohei, Yukio Ando, Nádia Pereira Gonçalves, & Maria João Saraiva. (2013). Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis. Laboratory Investigation. 93(8). 911–920. 28 indexed citations
15.
Misumi, Yohei, et al.. (2013). Long-term outcomes of common atrioventricular valve plasty in patients with functional single ventricle. Interactive Cardiovascular and Thoracic Surgery. 18(3). 259–265. 27 indexed citations
16.
Misumi, Yohei, Mitsuharu Ueda, Konen Obayashi, et al.. (2011). Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy. Human Pathology. 43(1). 96–104. 7 indexed citations
17.
Sueyoshi, Takanao, Mitsuharu Ueda, Akira Sei, et al.. (2011). Spinal multifocal amyloidosis derived from wild-type transthyretin. Amyloid. 18(3). 165–168. 15 indexed citations
18.
Horibata, Yasuhiro, Mitsuharu Ueda, Masayoshi Tasaki, et al.. (2011). Transthyretin-derived amyloid deposition in the heart of an elderly Japanese population. Amyloid. 18(sup1). 180–181. 1 indexed citations
19.
Uchino, Miki, Taro Yamashita, Hirofumi Jono, et al.. (2010). Chain reaction of amyloid fibril formation with induction of basement membrane in FAP. Amyloid. 17. 108. 1 indexed citations
20.
Yamashita, Taro, Yukio Ando, Mitsuharu Ueda, et al.. (2009). A rapid and sensitive prenatal diagnosis of familial amyloidotic polyneuropathy ATTR Val30Met by mass spectrometry. Prenatal Diagnosis. 29(10). 930–933. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayoshi Tasaki Breakdown of academic impact, for papers by Taro Yamashita Breakdown of academic impact, for papers by Jeff Packman Breakdown of academic impact, for papers by Jian Guan Breakdown of academic impact, for papers by Mohga El‐Abbadi Breakdown of academic impact, for papers by Minjing Zou Breakdown of academic impact, for papers by Chunping Yu Breakdown of academic impact, for papers by Shujun Lin Breakdown of academic impact, for papers by Shiying Cui Breakdown of academic impact, for papers by Sharmistha Chakraborty
Rankless by CCL
2026